COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 144 participants.

Also called NCT04606459

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 144 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04606459
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04606459. Randomized; no masking; primary purpose treatment. Start 2021-04-01 (actual); primary completion 2025-10-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina
Acronym
COSIMA
Condition
Coronary Microvascular Disease
Condition
Refractory Angina
Intervention (Device)
Coronary sinus reducer
Intervention (Other)
Optimal medical therapy
Lead sponsor
Johannes Gutenberg University Mainz (class: other)
Collaborator
Shockwave Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04606459
Content hash
f4a262f1ab3f4079ec1da4d0bdedb7de7b1c7f73f6ec5fd84e8c487e15f75b9e